ADMA Biologics, Inc. (ADMA)Perceptive Advisors LLC reduced its stake -416K shares

467K

Shares reported · -416K vs prior quarter

0.08%

Disclosed portfolio weight

$4.21M

Reported value

Holdings as of

Mar 31, 2026

Filed

May 29, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. May 6, 2026Company filing · Form 8-K · ResultsReported its results
2. May 11, 2026Insider · First buy since 2023Director purchased ~$100K of ADMA shares in the open market
3. May 12, 2026InsiderDirector purchased ~$100K of ADMA shares in the open market
4. May 27, 2026InsiderDirector purchased ~$51K of ADMA shares in the open market

What came next

1. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for ADMA Biologics, Inc.

For ADMA Biologics, Inc., OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ADMA page.

How this filing works

• SEC Form 13F

Other disclosures at ADMA Biologics, Inc.

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 4May 28, 2026
• SEC Form 13F-HRMay 15, 2026

Everything OQRO holds on this company is on its ADMA page.